Genome Editing

Genetically edited iPSC-derived models

Genetically edited iPSC-derived models can help researchers better understand how specific genes contribute to disease pathogenesis at the molecular and cellular level in a tissue-specific nature.

Furthermore, they represent valuable platforms for identifying drug targets and studying drug mechanisms of action, paving the way for developing new therapeutic interventions for many genetic diseases that are currently untreatable.

Our custom cellular reprograming service and directed differentiation of iPSCs offers the possibility of generating many disease models from any genetic background.

By combining the power of CRISPR-Cas9 genome editing with our iPSC technology, we can create accurate cellular models of genetic conditions by introducing disease-causing mutations into healthy control cell lines.

We can also correct those mutations in genomes of patient-derived cells to provide the matched control cell line.

What we can do for you

Our custom iPSC genome editing service includes:


Optimized and highly efficient gene editing workflow for iPSCs

Screening a selection of gRNAs and resulting cell clones

Sequence verification of genotypes engineered:

  • – Homozygous and heterozygous knockouts
  • – Homozygous and heterozygous point mutations
  • – Tagged reporter cell lines

Pluripotency assessment of gene-edited cell lines

Let us know

Do you have any questions about our cell reprogramming services?

Our dedicated Services team can help you. Our cell reprogramming services can be tailored to meet your experimental requirements, helping you to save time and resources. Please also download our Statement of Use for further details.

Fill in the form and let us know about your special requirements

White Paper